EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte Studie

Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial

Rusha Bhandari iD, Kara Lukas iD, Kyuwan Lee, Justin Shamunee, Brady Almeida, Tati Guzman, Meagan Echevarria, Lanie Lindenfeld, Christian Nenninger, Aleksi Iukuridze, Sophia Albanese, June-Wha Rhee and 4 more

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31369 ↗

At a glance

Randomisierte kontrollierte Studie in Pediatric Blood & Cancer, 2025. Written by Rusha Bhandari and 15 co-authors. Institution: Department of Population Sciences, City of Hope, Duarte, California, USA. Major MEDLINE topics: Cancer Survivors, Neoplasms, Feasibility Studies, Pyridinium Compounds. Cited 2 times so far (Crossref); 59 references. Funded by: NIH HHS, National Institutes of Health.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Childhood cancer survivors (CCS) have a 50% higher risk of diabetes mellitus (DM) compared with the general population. Interventions in survivors with prediabetes (fasting glucose 100‐125 mg/dL or hemoglobin A1c 5.7%‐6.4%) may mitigate the development of DM and its attendant morbidity, but there is limited information on the feasibility of secondary prevention in this setting.

Methods

This 6‐week pilot feasibility 1:1 randomized controlled trial enrolled 20 CCS on a structured telehealth exercise program ± nicotinamide riboside (NR), a nicotinamide adenine dinucleotide precursor. Feasibility metrics were: (1) ≥50% of eligible CCS enrolled onto study; (2) ≥70% of participants completed baseline and end‐of‐study assessments; (3) ≥70% compliance with exercise and NR. Secondary endpoints included changes in biomarkers associated with glucose homeostasis and muscle health.

Results

Median age (years) at cancer diagnosis was 16.5 (range, 1.5‐21.5) and 35.5 (range, 18.0‐67.0) at study enrollment. Enrollment rate was 87%, and 85% of participants completed baseline and end‐of‐study assessments. The mean percentage of exercise sessions completed was 86.6%; NR compliance was > 90%. There were no severe adverse events attributable to study interventions. Secondary endpoints were not significantly different between study arms at study completion. Myostatin decrease was observed in participants who completed a higher median number of exercise sessions and was associated with decreased intramuscular adipose tissue and increased lower extremity muscle cross‐sectional area.

Conclusions

A telehealth exercise intervention ± NR supplementation was feasible in CCS with prediabetes. Future studies in larger cohorts may be needed to evaluate their beneficial effects on muscle health and DM risk among CCS.

Subjects

MeSH terms (MEDLINE)

Cancer SurvivorsNeoplasmsFeasibility StudiesPyridinium CompoundsDietary SupplementsNiacinamideTelemedicineHumansPilot ProjectsFemaleMaleChildAdolescentAdultYoung AdultChild, PreschoolDiabetes MellitusInfantMiddle AgedExercise TherapyExercisePrognosisFollow-Up Studies

Author keywords

Childhood cancer survivornicotinamide ribosideprediabetesremote exercise

Substances

nicotinamide-beta-ribosidePyridinium CompoundsNiacinamide

Authors and institutions

  • Department of Population Sciences, City of Hope, Duarte, California, USA.
  • Department of Pediatrics, City of Hope, Duarte, California, USA.
  • Department of Medicine, City of Hope, Duarte, California, USA.
  • Department of Diabetes and Cancer Metabolism, City of Hope, Duarte, California, USA.

ORCID profiles: Rusha Bhandari, Kara Lukas, Saro H Armenian

Funding

  • NIH HHS
  • National Institutes of Health

Cite

APA

Bhandari, R., Lukas, K., Lee, K., Shamunee, J., Almeida, B., Guzman, T., Echevarria, M., Lindenfeld, L., Nenninger, C., Iukuridze, A., Albanese, S., Rhee, J. W., Chen, S., Brenner, C., Wong, F. L., & Armenian, S. H. (2025). Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31369

Vancouver

Bhandari R, Lukas K, Lee K, Shamunee J, Almeida B, Guzman T, et al. Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31369

BibTeX
@article{Bhandari2025,
  author = {Bhandari, Rusha and Lukas, Kara and Lee, Kyuwan and Shamunee, Justin and Almeida, Brady and Guzman, Tati and Echevarria, Meagan and Lindenfeld, Lanie and Nenninger, Christian and Iukuridze, Aleksi and Albanese, Sophia and Rhee, June-Wha and Chen, Sitong and Brenner, Charles and Wong, F Lennie and Armenian, Saro H},
  title = {Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31369}
}
Start for free →